| __timestamp | Sarepta Therapeutics, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9757000 | 4320000 |
| Thursday, January 1, 2015 | 1253000 | 2538000 |
| Friday, January 1, 2016 | 5421000 | 3337000 |
| Sunday, January 1, 2017 | 154584000 | 4003000 |
| Monday, January 1, 2018 | 301034000 | 8386000 |
| Tuesday, January 1, 2019 | 380833000 | 4461000 |
| Wednesday, January 1, 2020 | 540099000 | 1050000 |
| Friday, January 1, 2021 | 701887000 | 2963000 |
| Saturday, January 1, 2022 | 933013000 | 1772000 |
| Sunday, January 1, 2023 | 1243336000 | 314000 |
Unlocking the unknown
In the competitive world of biotechnology, revenue growth is a key indicator of success. Over the past decade, Sarepta Therapeutics, Inc. has emerged as a leader, showcasing a remarkable revenue increase of over 12,000% from 2014 to 2023. Starting with a modest revenue in 2014, Sarepta's financial journey has been nothing short of extraordinary, reaching a peak in 2023.
In contrast, Viridian Therapeutics, Inc. has faced challenges in scaling its revenue, with a peak in 2018 and a subsequent decline. By 2023, Viridian's revenue had decreased significantly, highlighting the volatile nature of the biotech industry.
This comparison underscores the dynamic landscape of biotechnology, where innovation and strategic decisions can lead to vastly different financial outcomes. As investors and stakeholders look to the future, the lessons from these two companies offer valuable insights into the industry's potential and pitfalls.
Revenue Showdown: Eli Lilly and Company vs Sarepta Therapeutics, Inc.
Breaking Down Revenue Trends: Vertex Pharmaceuticals Incorporated vs Viridian Therapeutics, Inc.
Dr. Reddy's Laboratories Limited or Sarepta Therapeutics, Inc.: Who Leads in Yearly Revenue?
Sarepta Therapeutics, Inc. vs Walgreens Boots Alliance, Inc.: Annual Revenue Growth Compared
Revenue Insights: Sarepta Therapeutics, Inc. and Exelixis, Inc. Performance Compared
Sarepta Therapeutics, Inc. vs Mesoblast Limited: Annual Revenue Growth Compared
Breaking Down Revenue Trends: Alkermes plc vs Viridian Therapeutics, Inc.
Veracyte, Inc. vs Viridian Therapeutics, Inc.: Examining Key Revenue Metrics
Revenue Insights: Bausch Health Companies Inc. and Viridian Therapeutics, Inc. Performance Compared
Geron Corporation vs Viridian Therapeutics, Inc.: Examining Key Revenue Metrics
Revenue Showdown: Taro Pharmaceutical Industries Ltd. vs Viridian Therapeutics, Inc.
Novavax, Inc. or Viridian Therapeutics, Inc.: Who Leads in Yearly Revenue?